A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19
Clinical trial NCT04347031 · COMPLETED
Trial details
- NCT number
- NCT04347031
- Sponsor
- Burnasyan Federal Medical Biophysical Center
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-08
- Primary completion
- 2020-11-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.